Altmeyer Anne sold CRBP
October 20, 2025 · Form 4 insider transaction
Altmeyer Anne sold 1,060 shares of Corbus Pharmaceuticals Holdings, Inc. at $20.50 per share, a transaction worth $21.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,060
Price
$20.50
Total value
$21.7K
InsiderAltmeyer Anne
RoleDirector
SecurityCommon Stock, par value $0.0001 per share
Transaction codeS: Open-market sale
Transaction dateOctober 20, 2025
Filing dateOctober 21, 2025
Shares owned after6,191
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.; This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant.